Novel blood test identifies biomarkers in patients with Alzheimer's disease
Early results from PharmaKure, a pharmaceutical company spun out from The University of Manchester, shows a novel whole blood test developed by the company is able to quantify Alzheimer's disease biomarkers.
Oct 17, 2023
0
0